CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients
Clinical trial NCT05533008 · COMPLETED
Trial details
- NCT number
- NCT05533008
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2020-06-11
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.